Research articlePublished 26 Oct 2022

PEG-PLA bio-instinct drug carrier: Trigger the formative size distribution and potential role in site specific therapy

Authors: Somnath Surai, Jing Yao, Saptarshi Panigrahi, Anusree Surai

International Journal of Drug Development and Research

Volume 14 · Issue 10 · Pages 1–15

Ask about this article

Abstract

Select any words in the title or abstract, or press this and choose a sentence.

An era of innovative nanotechnology, amphiphilic block polymeric drug vehicle claims the significant role in modern platforms like cancer therapy and diagnosis for sites specific tumor cells. Through this investigation of drug carrier like synthesis of amphiphilic PEG-PLA, gets more priority for its favorable physicochemical characteristics including steric stability, flexible size, modifiable surface and high encapsulation etc. Furthermore, PEG-PLA improves phagocytes, prolongs systemic circulation of drugs, improves cellular uptake and prevents normal cellular cytotoxicity. Therefore it is safe and efficacious in targeted therapy. It can mimic the natural components of the body which causes the versatile intellect like potential drug delivery and P-gp inhibition. Consequently, it diminish the toxicity of drugs and trigger the drugs to reach the destination without interfere of normal cells. In recent innovations, there has been increasing both the synthesis of PEG-PLA copolymer and its modifications which have been investing characteritics, formulation, drug release profile and prospective pharmaceutical application extensively. In our review, we will reflect the current innovation and prominent evaluation of drugs with PEG-PLA polymeric designs. Also, clarify the admissible technical contribution and benefits of this literature. It has provided the noticeable features of each assemble of PEG-PLA nano-formulation. This snap view has established the great impact and figure out the new insights of PEG-PLA drug delivery system which would be helpful in further research.

Ask about this article

Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. EuroSciCon does not store it.

Try:

More from this journal

The newest in International Journal of Drug Development and Research.

All its articles

Follow

New articles from what you follow go into your email digest, once you agree to alert emails.

  • JournalInternational Journal of Drug Development and Research
  • SubjectPharmaceutical Sciences
  • BylineArticles whose byline prints “Somnath Surai”
  • BylineArticles whose byline prints “Jing Yao”
  • BylineArticles whose byline prints “Saptarshi Panigrahi”
  • BylineArticles whose byline prints “Anusree Surai”